Riversedge Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $700K | Buy |
3,773
+96
| +3% | +$17.8K | 0.14% | 52 |
|
|
2025
Q1 | $770K | Buy |
3,677
+38
| +1% | +$7.96K | 0.17% | 52 |
|
|
2024
Q4 | $647K | Buy |
3,639
+84
| +2% | +$14.9K | 0.15% | 52 |
|
|
2024
Q3 | $702K | Buy |
3,555
+85
| +2% | +$16.8K | 0.16% | 48 |
|
|
2024
Q2 | $595K | Sell |
3,470
-9
| -0.3% | -$1.54K | 0.15% | 48 |
|
|
2024
Q1 | $633K | Buy |
3,479
+106
| +3% | +$19.3K | 0.16% | 44 |
|
|
2023
Q4 | $523K | Sell |
3,373
-326
| -9% | -$50.5K | 0.14% | 48 |
|
|
2023
Q3 | $551K | Buy |
3,699
+681
| +23% | +$102K | 0.16% | 45 |
|
|
2023
Q2 | $407K | Buy |
3,018
+4
| +0.1% | +$539 | 0.11% | 51 |
|
|
2023
Q1 | $480K | Buy |
3,014
+383
| +15% | +$61K | 0.14% | 51 |
|
|
2022
Q4 | $425K | Buy |
2,631
+131
| +5% | +$21.2K | 0.14% | 54 |
|
|
2022
Q3 | $336K | Hold |
2,500
| – | – | 0.12% | 60 |
|
|
2022
Q2 | $383K | Hold |
2,500
| – | – | 0.14% | 53 |
|
|
2022
Q1 | $405K | Sell |
2,500
-58
| -2% | -$9.4K | 0.13% | 50 |
|
|
2021
Q4 | $346K | Buy |
2,558
+58
| +2% | +$7.85K | 0.11% | 55 |
|
|
2021
Q3 | $270K | Hold |
2,500
| – | – | 0.09% | 53 |
|
|
2021
Q2 | $282K | Hold |
2,500
| – | – | 0.1% | 44 |
|
|
2021
Q1 | $271K | Hold |
2,500
| – | – | 0.12% | 39 |
|
|
2020
Q4 | $268K | Hold |
2,500
| – | – | 0.12% | 41 |
|
|
2020
Q3 | $219K | Hold |
2,500
| – | – | 0.12% | 44 |
|
|
2020
Q2 | $245K | Buy |
+2,500
| New | +$245K | 0.14% | 36 |
|